SGT

Diagnosing Lung Cancer - Supported by AstraZeneca

Speaker

Abstract

The burden of NSCLC is undeniably an issue in any part of the worlds, where majority of its detection is being done in advanced & metastatic stage. In this talk, we will emphasise on early detection as well as optimised diagnostic procedures to reduce the burden of lung cancer.


You May Also Like
Loading Comments...